A $100 million settlement between the owners of New England Compounding Center, the Massachusetts pharmacy connected to a deadly meningitis outbreak in 2012, and its controlling trustee was filed in bankruptcy court yesterday, the Wall Street Journal reported today. Under the settlement, the New England Compounding Center, its insurers and one of the company's affiliates will contribute more than $100 million to a compensation fund to be distributed to the pharmacy's creditors, including those who died or suffered significant injuries after receiving injections of tainted steroids traced to the pharmacy. The settlement, which had been expected, still requires approval from Judge Henry J. Boroff of the U.S. Bankruptcy Court in Boston before distributions can be made to victims. The trustee, Paul D. Moore, said he hopes to complete the process by the end of the year.
